These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9592977)
41. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer]. Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413 [TBL] [Abstract][Full Text] [Related]
42. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. Damiani D; Michelutti A; Michieli M; Masolini P; Stocchi R; Geromin A; Ermacora A; Russo D; Fanin R; Baccarani M Br J Haematol; 2002 Mar; 116(3):519-27. PubMed ID: 11849207 [TBL] [Abstract][Full Text] [Related]
43. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study. Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255 [TBL] [Abstract][Full Text] [Related]
44. The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia. Styczyński J; Wysocki M; Debski R; Kurylak A; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A Acta Biochim Pol; 2002; 49(1):99-107. PubMed ID: 12136962 [TBL] [Abstract][Full Text] [Related]
45. Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia. Merlin JL; Marchal S; Ramacci C; Notter D; Vigneron C Int J Hyperthermia; 1995; 11(6):855-65. PubMed ID: 8586906 [TBL] [Abstract][Full Text] [Related]
46. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169 [TBL] [Abstract][Full Text] [Related]
47. The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. List AF Leukemia; 1996 Apr; 10 Suppl 1():S36-8. PubMed ID: 8618469 [TBL] [Abstract][Full Text] [Related]
48. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Xie XY; Robb D; Chow S; Hedley DW Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279 [TBL] [Abstract][Full Text] [Related]
49. P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia. Tidefelt U; Liliemark J; Gruber A; Liliemark E; Sundman-Engberg B; Juliusson G; Stenke L; Elmhorn-Rosenborg A; Möllgård L; Lehman S; Xu D; Covelli A; Gustavsson B; Paul C J Clin Oncol; 2000 May; 18(9):1837-44. PubMed ID: 10784624 [TBL] [Abstract][Full Text] [Related]
50. [Expression of lung resistance protein and multidrug resistance protein genes in bone marrow cells of acute leukemia patients and its clinical significance]. Chi ZH; Liu Z; Sun C; Zhao HG; Liu JL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):472-5. PubMed ID: 14575539 [TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. Schroeijers AB; Scheffer GL; Flens MJ; Meijer GA; Izquierdo MA; van der Valk P; Scheper RJ Am J Pathol; 1998 Feb; 152(2):373-8. PubMed ID: 9466563 [TBL] [Abstract][Full Text] [Related]
52. [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs]. Machaczka M; Rucińska M; Jabłoński M; Skotnicki AB Przegl Lek; 1998; 55(7-8):407-13. PubMed ID: 10021886 [TBL] [Abstract][Full Text] [Related]
53. Expression of functional markers in acute nonlymphoblastic leukemia. Han K; Kahng J; Kim M; Lim J; Kim Y; Cho B; Kim HK; Min WS; Kim CC; Lee KY; Kim BK; Kang CS Acta Haematol; 2000; 104(4):174-80. PubMed ID: 11279307 [TBL] [Abstract][Full Text] [Related]
54. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival. Borg AG; Burgess R; Green LM; Scheper RJ; Yin JA Br J Haematol; 1998 Dec; 103(4):1083-91. PubMed ID: 9886324 [TBL] [Abstract][Full Text] [Related]
55. Coexpression of multidrug resistance involve proteins: a flow cytometric analysis. Boutonnat J; Bonnefoix T; Mousseau M; Seigneurin D; Ronot X Anticancer Res; 1998; 18(4C):2993-9. PubMed ID: 9713498 [TBL] [Abstract][Full Text] [Related]
56. Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. Filipits M; Pohl G; Stranzl T; Suchomel RW; Scheper RJ; Jäger U; Geissler K; Lechner K; Pirker R Blood; 1998 Mar; 91(5):1508-13. PubMed ID: 9473213 [TBL] [Abstract][Full Text] [Related]
57. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma]. Leng WD; Wang DZ; Feng G; He J Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692 [TBL] [Abstract][Full Text] [Related]
58. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia. Den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ Leukemia; 1999 Dec; 13(12):2023-30. PubMed ID: 10602424 [TBL] [Abstract][Full Text] [Related]
59. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006 [TBL] [Abstract][Full Text] [Related]
60. Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia. Dorr R; Karanes C; Spier C; Grogan T; Greer J; Moore J; Weinberger B; Schiller G; Pearce T; Litchman M; Dalton W; Roe D; List AF J Clin Oncol; 2001 Mar; 19(6):1589-99. PubMed ID: 11250987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]